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Autism is a behavioral syndrome characterized by a 
severe impairment of reciprocal social relations, and of 
verbal and nonverbal communications . Many different 
etiologic factors such as viral infection and genetic 
predisposition have been proposed to explain the development 
of this disorder. Immune abnormalities, such as a decreased 
lymphoblastic response to T-cell mitogen, defective ant i body 
responses to rubella vaccine, and decreased numbers of T 
lymphocytes , also have been identified in a subpopu l at i on of 
patients with autism, which implies t hat t h e deve l opme n t of 
autism in some cases may be due to auto i mmune mechan i sms . 
Recent evidence suggests that immune r esponse to the 
heat-shock proteins 60 and 70 is associated with seve r al 
autoimmune diseases, including juvenile arthritis, type I 
diabetes, and multiple sclerosis . Therefore , in this study , 
the plasmas of patients with autism were examined by enzyme-
viii 
linked immunosorbent assay (ELISA) for antibodies to the 
heat-shock proteins 60 and 70. 
The autistic subjects were found to have increased 
levels of antibodies against heat-shock protein 70 as 
compared to that of age-matched controls (p=O. 0148). 
However, levels of antibodies to heat shock protein 60 in the 
autistic subjects showed considerable individual variation 
and no significant difference was found. 
Abnormal immune reactions to myelin basic protein have 
also been found in autistic subjects. Since epitopes on 
myelin basic protein have been shown to crossreact with 
determinants on heat-shock protein 60, the similarity between 
anti-myelin basic protein monoclonal antibodies and anti-
heat-shock protein 60 antibodies in the autistic subjects was 
also studied. The results showed no crossreactivity between 
these two antibodies. 
In conclusion, the data from the study of antibodies 
against heat-shock protein 70 suggest an elevated immune 
response to heat-shock protein 70 in autistic subjects. This 




Autism is a biologically based developmental disorder 
arising during the first 36 months of life, which is commonly 
regarded as a pervasive neurodevelopmental disorder. This 
syndrome is identified by neuropsychiatric manifestations 
that include impairment of verbal or nonverbal communicative 
skills, bizarre responses to people's touch and objects, 
abnormal motoric mannerisms such as repetitive-rocking and 
self-inj urious behavior, and ease of irritation by minor 
changes in the immediate environment (Ritvo and Freeman, 
1978). Autism arises in all races and social classes without 
special di s tribution, and occurs three to four times more 
often in males than in females (Ornitz and Ritvo, 1976). 
Genetic, immunological, viral, and environmental mechanisms 
have been proposed as etiological factors for this severe 
behavioral disorder. However, no specific causes have been 
identified. Some investigations suggest that this disorder 
shares features with autoimmune disorders, including cell-
mediated immunity and/or antibodies against brain associated 
antigens (e.g., myelin basic protein) (Stubbs et al., 1977; 
Weizman et al., 1982; Warren et al., 1986; Warren et al., 
1990a; Yank et al., 1990; Singh et al., 1993). 
There is increasing evidence that heat -shock proteins 
(HSP) play an important r ole in autoimmunity, since increased 
anti b ody levels t o HSP cognates have been observed in 
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autoimmune diseases, including rheumatoid arthritis, 
ankylosing spondylitis, and systemic lupus erythematosus 
(Bahr et al., 1988; Tsoulfa et al., 1989). HSPs belong to a 
large family of proteins that are highly conserved in all 
organisms . They are synthesized by many kinds of cells in 
response to a broad range of stresses (e.g., heat and heavy 
metals) and function to protect cells against further stress. 
The extreme conservation of HSPs is a possible reason 
for their involvement in certain autoimmune diseases. 
Formation of autoantibodies may be caused by molecular 
mimicry ( epi tope homology) between microbial antigens and 
host proteins (Hedstrom et al., 1987) Moreover, some of the 
HSPs appear constitutively only after an encounter with 
various types of stresses. The immune system recognizes 
these stress-related HSPs as foreign, which results in a 
primary autoimmune reaction against such HSPs . 
HSPs are classified into families based on their 
molecular sizes (e.g., 90kDa, 70kDa, 60kDa, 20kDa). Among 
these, the HSP70 is one of the most abundant (Laemmli, 1970; 
Lindquist, 1986) The HSP70 gene is localized within the 
major histocompatibility complex (MHC) (Sargent et al., 
198 9) , which is of special interest, since Warren et al . 
(1991) have found an association between MHC genes and 
autism, including the extended haplotype (B44-SC30-DR4) 
(Warren et al., 1992). 
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The HSP70 gene is located within the 
extended haplotype and as such may be a susceptibility factor 
for the development of the neurobehavioral symptoms in 
autism. 
Another important heat-shock protein is the HSP60. This 
protein has been associated with autoimmunity because it has 
a high degree of homology with HSP65 found in microorganisms. 
It has been reported that the level of antibodies against 
HSP60 in schizophrenia patients is higher than in normal 
controls (Kilidireas et al . , 1992). 
As mentioned above, studies (Weizman et al., 1982; Singh 
et al., 1993) have shown abnormal immune reactions against 
myelin basic protein (MBP) in autism. Since myelin basic 
protein is known to share determinants with HSP60, it seems 
worthwhile to investigate whether the HSP60 antibody from the 
autistic subjects can compete with anti-MBP monoclonal 
antibody for binding to the HSP60 antigen. If the antibodies 
do compete, one can speculate that antibody against HSP60 
crossreacts with MBP in the brain, resulting in the 





Autism is a rare developmental disorder with reported 
frequencies varying from 0 . 7 to 4. 5 per 10,000 (Ritvo and 
Freeman, 1978). It is believed that the onset of this 
disorder occurs before birth or shortly after birth. 
However, autism is currently detectable beginning at about 
three years of age. Earlier diagnosis is difficult because 
there are no specific physical signs indicating autism during 
early infancy. Approximately 67 to 88 percent of classical 
autistic patients are mentally retarded (IQ < 70) (Gillberg et 
al. , 1991). The life span of autist ic subjects is the same 
as normal individuals. The current Diagnostic and 
Statistical Manual of Mental Disorders (DSM, American 
Psychiatric Association, 198 7) defines autism as a 
developmental disorder demonstrating qualitative impairment 
in social interaction, verbal and nonverbal communications, 
and in imaginative activity. The most common behavioral 
symptoms of autistic children can be classified as the 
following categories: 
1. Impairment of perception and relating. Disturbance 
of perception is common to all autistic patients. In many 
instances they do not responsd to either verbal commands or 
sounds , although sometimes they can respond to stimuli with 
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exaggerated reactions. These phenomena suggest that abnormal 
perceptions may be due to an underlying neuropatho-
physiological process (Tanguay, 1976). The result of 
impaired perception may cause disturbed relatedness (Hermelin 
and 0 'Connor, 1970), which includes absent social smile, 
apparent dislike of physical contact, and no interest in 
playing games with others. 
2. Disturbed motility . The disturbance of motility seen 
in autism is repeated body movements such as hand-flicking 
and/or twisting (APA, 1987). 
3. Impairment of speech and language. Autistic children 
have extreme difficulty in developing language and 
communication skills. Almost half of the population of 
autistic children never acquire functional language ability 
(Paul, 1987). 
Some other symptoms that are not among the diagnostic 
criteria of DSM- III -R but are common in autistic children 
include an abnormal response to sound (i .e. , no response to a 
sudden explosion but irritated by ordinary noise levels), 
bizarre response to pain, heat, or cold (i.e., no reaction to 
burn), difficulty in recognizing the things they see. 
To date, the etiology and pathogenesis of autism is 
unknown. It is believed that the behavioral syndrome of 
aut ism represents the f ina 1 express ion of a variety of 
etiological factors. These possible factors include genetic 
susceptibility (Folstein· and Rutter , 1977), viral infection 
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(Chess, 1971; Stubbs, 1987), and immunological dysfunctions. 
The latter includes decreased responsiveness of lymphocytes 
to mitogens (Stubbs et al., 1977), reduced function of 
natural killer cells (Warren et al., 1987), reduced numbers 
of T helper cells (Yonk et al., 1990), deficiency of 
suppressor-inducer (CD4+CD45RA+) T cells (Warren et al., 
1990b), an increased frequency of the null allele at the 
complement C4B locus (Warren et al., 1990), an increased 
incidence of the extended haplotype [B44-SC30-DR4), and 
immune abnormalities of cell-mediated immunity and/or 
antibodies against myelin basic protein. 
Genetic factors in autism 
Genetic disease is currently believed to be a possible 
cause of 10 to 20% of all cases of autism (Bolton and Rutter, 
1990; Gillberg, 1992). In England, Folstein and Rutter 
(1977) reported a 36% autism concordance rate in monozygotic 
twins and a 0% concordance rate in same-sex dizygotic twins. 
They concluded that genetic factors may play a part in the 
etiology of autism. DeMyer et al. ( 1981) surveyed a large 
population and found that between 2% and 6% of autistic 
probands have autistic siblings. Ritvo et al. (1989) did an 
epidemiological survey of autism in Utah and found that 
siblings of autistic patients have a 215 times greater chance 
of being autistic than siblings of non-autistic individuals. 
The frequency of developing autism for each sibling who is 
born after an autistic child is 8. 6%. Thus, the above 
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results indicate that there may be a subtype of autism that 
is genetically influenced. 
Several types of genetic patterns have been observed in 
patients with autism. First, aberrations of whole or pieces 
of chromosomes have been associated with autism. Gillberg et 
al . (1991) reported that a marker chromosome (extra material 
from the long arm of chromosome 15) is associated with a 
specific autistic syndrome. In addition, a fragile site 
(Xq27 .3) has been found in a number of autistic patients 
(Cohen et al., 1991). 
The results of a study on familial aggregation and 
genetic implications by Folstein and Rutter in 1988 suggested 
that it is not autism itself that is inherited but rather 
some genetic aberrations, s uch as language and/or sociability 
abnormalities, which combine with an environmental insult 
such as birth difficulties, resulting in autism. 
Immunopathogenesis and autism 
Stubbs (1976) found that a group of autistic children 
did not have rubella antibodies despite having a history of 
vaccination. This finding suggests that autistic children 
may lack the immune response to the rubella antigen, and 
implies a dysfunction in the immune system of autistic 
children. Stubbs et al. (1977) also measured T-cell 
stimulation by using phytohaemagglutinin (PHA) and B 
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lymphocyte responsiveness to pokeweed mitogen (PWM) of 12 
children with autism. It was shown that the autistic group 
had a depressed lymphocyte transformation response to PHA as 
compared to the normal controls, suggesting that children 
with autism have a relative T-cell deficiency. 
Weizman et al . (1982) examined a cell-mediated 
autoimmune response toward human MBP by the macrophage 
inhibition factor test in autistic s ubjects. Thirteen of 17 
autistic subjects showed inhibition of macrophage migration, 
whereas none of the controls demonstrated such a response. 
The results indicated that there may exist a cell-mediated 
immune response to brain tissue in autistic patients. 
In 1986, Warren et al. confirmed an earlier finding by 
Stubb s et al. (1977) that lymphocytes from autistic subjects 
have a defective response to the T-cell mitogen PHA and the 
B-cell mitogen PWM. A f urther s tudy by this group 
demonstrated a lower percentage and number of CD4+ T cells, a 
lower number of CD4+CD45RA+ T cells, and a lower p e rc e ntage 
and number of total lymphocytes in autistic subjects as 
compared to siblings and normal controls (Warren et al., 
1990b) . 
Neuropathogenesis in autism 
Some invest igat ors have reported that brainstem 
dysfunctions that severely disrupt the development of many 
higher cognitive functions may be involved in autistic 
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children (Ornitz, 1983) . Williams et al. (1980) examined the 
cerebral cortex of four indi victuals who showed prominent 
autistic features. They found subtle changes to the 
dendrites and spines of layer V pyramidal neurons of the mid-
frontal gyrus in two patients. They also found a reduced 
density of Purkinje cells in a familial case. 
The neuron-anatomical findings in autism from Yates 
(1984) show that many of the functional impairments 
constantly observed in autistic children suggest a damage to 
the left hemisphere of the brain . Bauman and Kemper (1985) 
performed an autopsy on the brain of a man with autism who 
died by drowning. They found a marked loss of Purkinje cells 
and some loss of granule cells in the neocerebellum. 
Ritvo et al. (1986) studied the cerebellum of four 
patients and the pathology results showed that one patient 
had microgyria of the occipital and temporal lobes and total 
Purkinje cell counts of each of the four patients were 
significantly lower than those of comparison cases. 
Autoimmune disorder and autism 
In 1971, Money et al. reported that infantile autism and 
autoimmunity occurred coincidentally in a family and 
postulated that autoantibodies may affect the central nervous 
system. Sullivan (1975) found an increased incidence of the 
autoimmune disorder rheumatoid arthritis in families of 
autistic children, and Raiten and Massaro also found the same 
situation in 1986. 
10 
Stubbs (1987) noted the occurrence of an 
autoimmune disorder, systemic lupus erythematosus (SLE), in a 
mother of an autistic child. They also found several other 
mothers of autistic children having a presumed diagnosis of 
SLE. Todd and Ciaranello (1985) found that 9 of 30 autistic 
children had antiserotonin autoantibodies to brain serotonin 
receptors, in contrast to 0% in groups of control children. 
Singh et al. (1991) demonstrated that the soluble 
cytokines interleukin-2 (products of activated immunocytes) 
and T8 are increased in the sera of children with autism. 
These cytokines have also been found in other autoimmune 
diseases such as systemic lupus erythematosus and multiple 
sclerosis (Huang et al., 1988; Trotter et al., 1988). 
Warren et al. (1991) studied the frequency of the null 
allele at the complement C4B locus in autistic subjects and 
their siblings. They found that there is an increased 
phenotypic frequency of the C4B null allele in autistic 
subjects and mothers, whereas the fathers had normal 
frequencies of this null allele. In a subsequent study, they 
found that inheritance of the null allele is associated with 
reduced C4B serum levels, which may be allowing an infectious 
agent or immune complex to persist, resulting in prolonged 
immunological stimulus and triggering of an autoimmune 
reacti.on (Warren et al., 1994). Warren et al. (1992) 
demonstrated that autism, like other autoimmune diseases, 
also exhibits associations with particular alleles of the 
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major histocompatibility complex (MHC), located on chromosome 
6. According to the above information, one can propose that 
some cases of autistic disorders may be associated with an 
autoimmune disorder. 
Much evidence indicates that heat-shock proteins have a 
role in autoimmunity. Increased antibody levels to HSP 
cognates have been observed in different autoimmune disorders 
such as antibodies to HSP65 in rheumatoid arthritis and HSP70 
in systemic lupus erythematosus (Bahr et al., 1988; Minota et 
al., 1988; Tsoulfa et al., 1989). 
The nature of HSP 
HSPs, a large family of proteins highly conserved 
between species , 
eukaryotic cells. 
are synthesized by prokaryotic and 
Some families of HSPs are induced by a 
variety of insults that promote protein denaturation and 
misfolding, while others play vital roles in normal cell 
f unction and are synthesized constitutively. Both of these 
types , induced and constitutively synthesized HSPs, are 
closely related in amino acid sequence. 
The physiological functions of HSPs include the 
fol lowing: First, HSPs bind to other proteins and modify 
their destiny and function (Craig, 1985; Rothman, 1989) . For 
example , HSP90 binds to steroid receptors, preventing the 
i nteraction between steroid receptors and nuclear DNA until 
the steroid hormone is bound. Without the presence of HSP90, 
steroid receptors would 
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interact with nuclear DNA 
independently, which would cause the premature and senseless 
interaction between steroid receptors and DNA (Sanchez and 
Housley, 1987). Second, HSPs have the ability to help the 
folding, unfolding, and translocation of polypeptides as well 
as the assembly and disassembly of oligomeric protein 
complexes (Cheng et al., 198 9) . The disassembly of 
oligomeric complexes and the unfolding of polypeptides occur 
under stress conditions such as high temperature and the 
reactive oxygen metabolites that frequently occur during the 
course of inflammation (Polla, 1988) . It is probably a major 
role for HSP to prevent or reverse those events. 
The major HSPs of most organisms can be classified by 
their sizes. They fall into size classes of approximately 80 
to 90, 68 to 75, and 15 to 30 kilodaltons. Among these, the 
HSP70 proteins are a major group that account for 1% of total 
cellular protein (P elham, 1986) and are extremely conserved 
within species. The HSP70 family consists of five different, 
but structurally and immunologically related proteins: (1) a 
constitutive 73kDa protein; (2) a stress-inducible 72kDa 
protein; (3) a stress-inducible 73kDa protein; (4) a 
constitutive 74-78kDa protein present in the endoplasmic 
reticulum ; and (5) a 75-kDa member present in the 
mitochondria (Lindquist, 1986; Schlesinger, 1986) . The 
inducible HSP70 proteins are thought to aid in protein repair 
(Pelham, 1986), while the constitutive HSP70 proteins are 
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known to participate in disassembly of clathrin vesicles 
(Chapel et al., 1986) and in assembly of immunoglobulin 
molecules. 
HSP60 is the first mitochondrial component known to be 
essential in the process of folding and assembly of proteins 
imported into the mitochondria (Ostermann et al., 1989). It 
is a nuclear-coded, constitutively expressed heat-shock 
protein existing in the mitochondrial matrix. The HSP60 
equivalent has been found in mitochondria from several 
sources. Since HSP60 can assist in oligomeric protein 
assembly, the loss of HSP60 function causes the failure of 
precursor proteins to assemble into functional proteins. 
More recently, HSP70 and HSP60 from several species of 
parasites and bacteria have been shown to be antigenic 
(Bianco et al., 1986). As mentioned before, a host may 
experience stress induced by its predators, which may lead to 
increased HSP synthesis. Due to the increased amount of HSP, 
or perhaps for other reasons, HSPs become prominent antigens 
that trigger a major portion of the immune repertoire. 
Antibodies against HSP cognates have been found in 
infections with many parasites (Ternynck et al., 1991). It 
is not clear whether this type of immunity can confer the 
protection against microbial pathogens. However, it has been 
proposed that this immunity adds to resistance at early 
stages of infections (Kaufmann, 1990). 
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HSP and autism 
Since members of the HSP70 family are highly conserved 
at the amino acid level among eukaryotes and prokaryotes 
(Lindquist, 1986; Pelham, 1986), it has been suggested that 
the HSP70 family may play a role in autoimmunity. The 
antibodies induced against microbial HSP70 may crossreact 
with HSP70 from the host, leading to the development of 
autoimmune disorders. Furthermore , it has been demonstrated 
that three HSP70 genes are mapped in the human major 
histocompatibility complex (MHC) on chromosome 6 between the 
loci for complement components and the tumor necrosis factor 
(Sargent et al., 1989; Romano et al., 1989; Milner and 
Campbell, 1990) . The MHC is a group of closely linked loci 
coding for surface molecules involved in many aspects of the 
immune response. The level of DNA polymorphism in human MHC 
is very high, creating many allelic patterns within MHC 
genes. It has been found that a combination of specific MHC 
allele s (extended haplotype) occurs more often than normal in 
subjects with certain autoimmune diseases (Alper et al., 
1989). Warren et al. (1992) recently reported that one 
particular combination of MHC alleles B44-SC30-DR4 (HLA-B, 
BF, C2, C4A, C4B null allele, HLA-DR4) was increased by 
almost six-fold in autistic patients as compared with normal 
subjects. Therefore, they s ugge sted that a gene some where 
within the ext ended haplotype is associated wi th 
manife stat ion of some cases of autism . Since the gene of the 
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HSP70 family has been mapped close to the extended haplotype, 
it is conceivable that HSP70 is responsible for the 
development of the neurobehavioral symptoms in autism. 
Another important member in the HSP family is HSP60. 
Jones et al. (1993) identified that 19 known autoantigens are 
similar to regions of this HSP, and the regions of sequence 
similarity between them occurred at sites of high potential 
antigenicity. Also, the HSP60 is highly conserved within 
most organisms . Therefore, HSP60 has been associated with 
several autoimmune diseases. For example, a region (155-175) 
of human HSP60 is similar to the region (98-118) of a DQ 
alpha peptide. In primary biliary cirrhosis (PBC), the 
autoimmune destruction of HLA class II-bearing bile duct 
cells may be due to the similarities between T-ce11 epitopes 
in PBC-associated antigens and HLA-DR<l (Burroughs et al. , 
1992). 
Anti-MBP antibody and autism 
Abnormal immune response to MBP has been found to be 
associated with multiple sclerosis (Waksman, 1981) and 
encephalitis (Desai et al., 1994). In 1982, Weizman et al. 
found that some autistic subjects make inappropriate cell-
mediated immune response toward a component of brain myelin, 
MBP. In addition , Singh et al. (1993) examined the 
possibilit y of humoral - mediated autoimmune response toward 
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myelin basic protein in the syndrome of autism. 
Approximately 58% (19 of 33) of sera from autistic children 
were found to be positive for MBP antibodies. Moreover, 
Musiek et al. (1984) suggested that tardy or incomplete 
myelination in the corpus callosum is the basis of auditory 
processing problems in some learning disability children. 
McClelland et al. (1992) also reported a maturational defect 
in myelination within the brain-stem in 11 autistic children. 
Therefore, it is possible that an immunological invasion 
(i.e . , autoantibodies) occurred after a viral infection, 
prenatally or postnatally, resulting in poor myelination or 
abnormal function of the neuron-axon myelin. Thus it is 
conceivable that anti-MBP antibodies may be associated with 
the development of neurobehavioral problems in a subgroup of 
the autistic subjects. 
General principles of assay methods 
Study of anti-HSP60 antibodies. The method used for 
detecting HSP60 antibody is the indirect solid-phase enzyme-
linked immunosorbent assay (ELISA) . In this assay, antigen 
is immobilized onto the surface of a microtiter well, and 
patient and control plasmas are added to react with the 
absorbed antigens. The unreacted molecules are washed away, 
and an enzyme-labeled anti-human immunoglobulin secondary 
antibody is added. Finally, color is developed with addition 
of a substrate. 
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The specificity of the HSP60 antibody assay results are 
confirmed using a competitive ELISA and an antibody 
competition assay. In the competitive ELISA, the positive 
plasmas (having a purportedly high antibody level to HSP60) 
are first incubated with the soluble HSP60 antigen. If the 
plasma contains the specific antibody, this antibody will be 
absorbed onto the soluble antigen (the soluble antigen used 
is the same as the antigen coated on the solid phase) . After 
the adsorption process, part of the solution (plasma-antigen) 
is transferred to the corresponding wells of an antigen 
plate. The enzyme-linked anti-human Ig is then added to the 
wells and the plate is developed by the addition of substrate 
to each well. Since the antibody specific to the antigen 
will have been removed by the adsorption process, the 
absorbance values for the wells (sample wells) containing 
competing antigen would be expected to be less than those of 
wells (control wells) without competing antigen. The wells 
without competing antigen should have the maximal reading of 
optical density (OD) . 
In the antibody competition assay, positive plasmas are 
mi xed with rabbit anti-HSP60 polyclonal antibody and added to 
the antigen (HSP60) - coated well . Control wells contain 
positive plasmas alone. If the antibodies compete for the 
binding to HSP60, the absorbance readings for the sample 
well s will be less than those of control wells. 
Study of antj-HSP70 antjbodjes. 
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The method for 
detecting HSP70 antibodies is the same as the method used 
above for detection of the HSP60 antibodies. The specificity 
of the reactivities is also studied with a competitive ELISA. 
This assay is similar to the competitive ELISA described 
above for HSP60 antibodies except that two kinds of soluble 
HSP70 antigens, obtained from different sources, are used. 
One of the soluble antigens is the same as that used to coat 
the plate. 
vendor. 
The other antigen is obtained from a different 
Inyestigation of crossreactiyity between patjent anti-HSP60 
antjbodjes and antj-MBP monoclonal antibodies. Sharing of 
epitopes between patient antibodies and anti-MBP monoclonal 
antibodies is examined by using an antibody competition 
assay. This assay is similar to the antibody competition 
assay described above except that it uses two kinds of anti-
Ig secondary antibodies. In two microtiter plates, anti-
HSP60 antibody in patient plasma is mixed with anti-MBP 
monoclonal antibody for competing binding to HSP60 coated in 
the plates. In the first plate, the addition of anti-human 
polyvalent immunoglobulins conjugated with alkaline 
phosphatase is used to measure the level of anti -HSP60 
antibodies from patient plasma which have bound to the 
coating antigen. The wells without competing antibody are 
the control wells which will have the maximal reading of OD. 
If the anti-MBP monoclonal antibody can compete with anti-
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HSP60 antibody for binding to HSP60 antigen, the OD values of 
the wells with competing antibody will be less than those of 
wells without competing antibody. In the second plate, the 
conjugate anti-mouse IgG is added to detect the amount of 
anti-MBP monoclonal antibodies which have bonded with the 
coating antigen. The control wells contain the anti-MBP 
monoclonal antibody plus coating antigen. If the anti-HSP60 
antibody competes with anti-MBP monoclonal antibody for 
binding to the antigen, the OD values of the sample wells 
will be lower than those of control wells. 
CHAPTER II I 
MATERIALS AND METHODS 
Experimental subjects 
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This study included 41 autistic subjects (7 females and 
34 males) ranging in age from 3 to 27 years from whom plasmas 
were obtained and stored in conjunction with previous studies 
carried out in the Biomedical Laboratory of the Center for 
Persons with Disabilities. All of the patients met DSM-IIIR 
criteria for autism as evaluated by at least one psychiatrist 
and confirmed by a psychologist. They had no medical 
problems or sign of infection and/ or allergies at the time 
blood samples were collected. Thirty-two healthy, age-
matched controls (9 females and 23 males) were also studied 
who were living in the same geographical area (northern Utah) 
as the autistic patients. 
European ancestry. 
Plasma preparation 
All subjects were of northern 
Blood samples were obtained by venipuncture during early 
morning hours via informed consent procedures. The plasma 
was separated from the blood by centrifugation at 2000 rpm 
for 15 minutes, aliquoted, and stored at -700 C until used. 
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Plasma standard for assays 
In order to conduct this investigation, it was necessary 
to perform the ELISA on several different days. Therefore, 
to control for day-to-day variation, a plasma sample known to 
have antibodies against HSP60 or HSP70 (standard plasma) was 
included each time the assay was performed . 
Sources of HSP60 and HSP70 
The HSP70 (Sigma, St Louis, MO.) was purified from 
bovine brain following homogenization with Tris-HCL buffer 
(buffer A) containing 2-mercaptoethanol. After 
centrifugation the supernatant was fractionated with ammonium 
sulfate. Following centrifugation and dialysis, the sample 
was chromatographed on a DEAE-cellulose column. The proteins 
were eluted with a salt gradient and fractions at 0.1-0.2 M 
NaCl were pooled , and further purified by an ATP-agarose 
column . 
The HSP70 (StressGen Victoria, B.C., Canada) was 
purified from fresh bovine brain. The method of purification 
follows the techniques described by Schlossman et al. (1984). 
The HSP60 (Epicentre Technologies, Madison, WI) was purified 
from E. coli bearing plasmid pOF39. Cultures of E. coli were 
grown to late log phase at 37oc, col lected by centrifugation 
at 4oc, and resuspended in ice-cold Tris-saline containing 
protease inhibitors. After lysing by sonication, the 
suspension was centrifuged and fractionated by ammonium 
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sulfate precipitation. The ammonium sulfate cut was 
resuspended in Tris-saline and applied to a gel-filtration 
column. Fractions containing proteins were pooled, diluted 
with distilled water, and applied to a Q-Sepharose column 
equilibrated with bis-Tris-HCL and KCL. HSP60 was eluted 
with a KCL gradient and the protein was further purified by 
Mono-Q FPLC. 
Buffers 
1. Washing buffer: phosphate buffered saline (PBS) 
containing 0. 05% Tween-20 (PBS-T, pH 7. 4) was used for all 
washing procedures of ELISA plates. 
2. Dilution buffer: PBS containing 0.05% Tween 20 and 1% 
bovine serum albumin (BSA) (PBS-T-BSA) was used for diluting 
antibodies, human plasma, and enzyme-labeled reagents. 
3. Blocking buffer: PBS containing 0.05% Tween 20 and 5% 
bovine serum albumin. 
4. Coating buffer: Carbonate buffer, pH 9.6 
5. Substrate buffer: 0. 05M diethanolamine buffer, pH 
9.8, containing 1 mM MgCl 2 . 
Study of anti-HSP60 antibodies 
The optimal concentrations of antigen and antibody for 
all assays were determined by checkerboard titrations. Wells 
of 96-well microtiterplates (E.I.A.II Plus microtitration 
plates from Linbro, McLean, VA) were coated with 100 Jll 
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( 1 IJ.g /ml) antigen, HSP60, in carbonate buffer (pH 9. 6) and 
incubated overnight at 4°C (the coating antigen concentration 
u sed in all assays wa s the same). Excess antigen was 
decanted and the wells were washed with PBS-T. The unbound 
sites in the wells were coated with proteins of the blocking 
so lution (100 IJ.l) at 37oc for one hour . The wells were 
washed with PBS-T and duplicates of 100 IJ.l of patient and 
control plasma diluted 1:50 and 1:100 in dilution buffer were 
added to test well s. Four controls were used in each assay 
including a coated solid-phase well with a negative plasma, a 
coated well with a standard plasma, an uncoated well with a 
standard plasma , and a coated well with all reactive 
reagents. Plates 
washing, 100 111 
(Sigma, St. Louis , 
were incubated overnight at 4°C. After 
of goat - anti-human polyvalent antibody 
MO) conjugated with alkaline phosphatase 
in 1:10,000 dilution (the conjugated antibody concentration 
used in all assay were the same) was added to each well and 
the plate was incubated at 4°C overnight. Following five 
washes , the en zyme -substrate reaction was developed by the 
addition of 100 IJ.l p-nitrophenol phosphate (1 mg/ml in 
substrate buffer) (Sigma, St. Loui s , MO) to each well. 
Absorbance was measured at 405 nm with a BIO-RAD microplate 
reader. 
In the competitive ELISA, 100 IJ. l (1 IJ.g /ml) of HSP60 
antigen was pipetted into each well of the microplate and 
incubated at 4oc overnight. An equal volume of positive 
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plasma (1:25 dilution) and soluble antigen (4 ~g/ml HSP60 in 
dilution buffer) were incubated for 90 minutes at 37°C in a 
siliconized tube in a humid environment. Si l icon i zation with 
dichlorodimethylsilane (Sigma) was used to prevent protein 
from sticking to the surface of tube. A control tube 
containing the positive plasma (1:50 dilution) was incubated 
in the same environment as the sample tube. Blocking 
solution was added to the plate and incubated for one hour at 
37oc. The plasma-antigen solution (100 ~1) and plasma only 
(100 ~1) were incubated with coating antigen overnight at 
The development of the ELISA with the conjugated 
antibody, addition of the substrate, and absorbance 
measurement were the same as the procedures used for 
detection of the HSP60 antibodies. 
The procedures for antibody competition assay were similar to 
the procedures used in the competitive ELISA except that 
anti-HSP60 polyclonal antibodies and patient 
incubated together. Duplicate 50 ~1 volumes 
dilution of rabbit anti-HSP60 polyclonal 
plasma were 
of a 1:100 
antibodies 
(Epicentre, Madison, WI) were added to the microtiter plate 
and allowed to bind for one hour at room temperature. 
Without washing, 50 ~1 of a 1:25 dilution of positive plasma 
was added in duplicate to the plate containing antigen and 
anti - HSP60 polyclonal antibodies and incubated at 4°C 
overnight. The control wells contained HSP60 as an antigen 
and 100 ~1 of a 1 : 50 dilution of positive plasma. 
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Study of anti-HSP70 antibodies 
The method for detecting HSP70 antibodies in patient and 
control plasmas was the same as that used in measuring the 
HSP60 antibodies. The specificity of the positive plasmas 
was studied by a competitive ELISA which was similar to that 
mentioned above for HSP60 antibodies. Microplates were 
coated with HSP70. The next step was separated into two 
parts. In the first part, an equal volume of positive plasma 
(1:25 dilution) and soluble HSP70 coating antigen (Sigma, St. 
Louis, MO) (4 ~g/ml in dilution buffer) were incubated in a 
siliconized tube for 90 minutes at 37oc in a humid 
environment. In the second part, soluble HSP70 antigen at 
concentration of 4 ~g/ml (StressGen, Victoria, B.C., Canada) 
was incubated with a positive plasma (1:25 dilution) in a 
siliconized tube. A tube containing the positive plasma 
(1:50 dilution) which gave the maximal OD was incubated in 
the same environment as the sample tubes. 
Investigation of crossreactivity 
between anti-HSP60 antibodies and 
anti - MBP monoclonal antibodies 
The procedures for this study were similar to the 
antibody competition assay described above except that two 
kinds of secondary conjugated antibodies were used. In one 
assay, duplicate 50-~1 volumes of 1:100 dilution of 
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monoclonal antibody with specificity for MBP (Boehringer 
Mannheim Biochemical, Indianapolis, IN) were added to the 
microtiter plate and allowed to bind for one hour at room 
temperature. Without washing, 50 Jl l of 1 :25 dilution (in 
dilution buffer) of positive plasma was added in duplicate to 
the plate containing HSP60 antigen and anti-MBP monoclonal 
antibody and incubated at 4°C overnight. The plate was 
washed five times in PBS-T, and 100 Jll of 1:10,000 dilution 
of alkaline phosphatase conjugate of anti-human polyvalent 
antibodies was added into plate. The control wells contained 
coating antigen (HSP60) and positive plasma (1:50 dilution). 
The second procedure was similar to that of the first assay 
except that the conjugated antibody used in the second assay 
was anti-mouse IgG conjugated with alkaline phosphatase 
(1 :2000 dilution in dilution buffer) The control wells 
contained coating antigen, HSP60, and anti-MBP monoclonal 
antibodies (1:200 dilution). 
Statistical analysis 
The OD from the assays was expressed as a ratio of the 
standard in each plate to adjust for the deviated results 
within each plate. Direct absorbance values were also used 
as an additional method to evaluate data. Statistical 
comparisons between autistic and control groups were made 
using Student's t test. Compar isons were also performed 
between autistic males and control males, and between 
autistic females and controls. Due to the limited number of 
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aut is tic females and control females , t h e compari son was made 
between autistic females and total cont r ols r ather tha n 
control females. 
The correlation coefficient was es t imated by simple 
regression analysis. 
In antibody competition assays , t h e percentage o f 
inhibition was calculated by the following formula: 
OD of wells without OD of wells with 
competing Ab competing Ab 
% inhibit ion= ---=-----=----------___:'------=:_---- X 100 
OD of wells without competing Ab 
CHAPTER IV 
RESULTS 
Study of anti-HSP70 antibodies 
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Circulating anti-HSP70 antibody levels as estimated by 
the 00 values in plasma samples calculated as a percentage of 
00 values in standard plasma are shown in Figures 1 and 2. 
Values in autistic subject plasmas diluted 1:50 were 
significantly elevated (median 29.24; range 8.79-100; 
P=O. 0148) as compared with those of the normal controls 
(17.37; 4.37-70.048) (Fig. 1) Similar results were obtained 
with plasma diluted 1:100 (Fig. 2) . In a comparison of the 
plasmas of the autistic males and control males, 00 ratios 
were significantly increased (P=0.0285) in the former (Fig. 
3) . The 00 ratios of plasmas of the autistic females were 
not significantly elevated when compared with normal female 
controls, but were significant (P=O. 0293) if compared with 
all (male and female controls) (Fig. 4). 
A direct comparison (without standard adjustment) of 
patient plasmas diluted 1:50 (Fig . 5) and 1:100 (Fig. 6) gave 
results similar to those obtained using the 00 ratio 
described above. Significant increases in 00 values in 
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Fig. 1. Antibody reactivity to HSP70 in plasmas of autistic 
subjects and normal controls. Shown are 00 ratios (00405 
sample/00405 standard) and median of plasmas diluted 1:50. 
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Fig. 2. Antibody reactivity to HSP70 in plasmas of autistic 
subjects and normal controls. Shown are OD ratios (OD405 
sample/OD 405 standard) and median of plasmas diluted 1:100. 













<!) • • 0 • "" 0 50 -. 0 
'- • 
"' • ...:! 40 • ··-~ • • 
Ul 30 • ·'!' <!) • 0 • ... 
"" 20 .,. 0 
"'- • 0 ••• • 




Fig . 3. Antibody reactivity to HSP70 in plasmas of autistic 
male subjects and normal male controls. Shown are OD ratios 
(00405 sample/OD 405 standard) and median of plasmas diluted 
1:50. Plasmas of autistic male sub j ects had significantly 
(P=0.0285) elevated ratios. 
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Fig. 4 . Antibody reactivity to HSP70 i n p las mas o f a ut i st i c 
fema l e subjects and normal cont ro l s. Shown are 00 r a tios 
(00 405 sample/00405 standard) a nd median of plas mas diluted 
1:50. Plasmas of autistic female subjects had sign i f ica ntly 




1. • w 
u • z ...: • •• Ol 
0:: 
0 
(f) • •• Ol #e ...: • .A' 
0.5 • ••• •• 
• ~-~·· • •• 




Fig . 5. Antibody reactivity to HSP70 in plasmas of autistic 
subjects and normal controls. Shown are absorbance values 
(median) from plasmas diluted 1:50. Plasmas of autistic 
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Fig. 6 . Ant i body reactivity to HSP70 in p l asmas of a utistic 
s ub j ects and norma l controls. Shown are a b sorbance val ues 
(median ) from plasmas diluted 1: 100 . Plasmas of aut is tic 
subjects had significantly (P=0.0041) elevated values. 
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The specificity of the results was studied in two 
different competitive assays . In the first, the plasmas 
giving high OD values were incubated with HSP70 (purchased 
from Sigma) in solution before pipeting them into antigen 
coated wells. The absorbance values obtained with these 
plasmas were significantly lower (P<O.OOOl) than those found 
with plasmas not incubated with the antigen solution (Fig. 
7). The second competitive assay was the same as the first 
one except that the soluble antigen was purchased from 
StressGen. The results were similar (P<O. 0003) to those 
found with antigen obtained from Sigma (Fig. 8). 
Study of anti-HSP60 antibodies 
The levels of anti-HSP60 antibodies in the plasmas of 
the 41 autistic subjects (median 19.24; range 0-100; 
P=0.1303) were not significantly increased as compared with 
those (10.63; 0.88-71.33) of normal healthy controls (Fig. 9 
and 10). Nevertheless, 13 out of 41 autistic subjects' (32 %) 
plasmas had significantly increased antibody levels above the 
95% confidence limits of the control group. The antibody 
levels in the plasmas of autistic males were significantly 
higher (P=O. 033 9) than those of normal controls (Fig. 11) . 
In contrast, the mean OD ratios between the autistic (28.1) 
and control females (29.1) were simi lar (Fig. 12). 
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1.0 
1 2 3 4 5 6 7 
SUBJECTS (PATIENTS AND CONTROLS) 
Fig . 7. Antibody reactivity to HSP70. Absorbance values 
from the wells without competing antigens (white bars) and 
with competing antigens (black bars) in plasmas of autistic 
subjects (#1, 2, 3, 4, & 5) and in plasmas of controls (#6, & 
7). The preparation of HSP70 antigen used to adsorb 
antibodies was different from that of HSP70 used to coat the 
plate. The absorbance values from the wells with competing 
antigens were significantly lower (P<O. 0003) than those of 
wells without competing antigens . 
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1 2 3 4 5 6 7 
SUBJECTS (PATIENTS AND CONTROLS) 
:Eig . 8 . Antibody reactivity to HSP70. Absorbance values 
from the wells without competing antigens (white bars) and 
the wells with competing antigens (black ba r s) in plasmas of 
aut i stic subjects ( #1 , 2, 3, 4, & 5 ) and in plasmas of 
controls ( #6, & 7 ) . The preparation of HSP 7 0 ant i gen used to 
adsorb antibodies was the same as that of HSP70 antigen used 
t o coat the plate. The absorbance values from the wells with 
competing antigens were significantly lower (P<O. 0001) than 
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Fi q . 9 . Antibody reactivity to HSP60 in plasmas of autistic 
subjects and normal controls. Shown are OD ratios (OD405 
sample/OD4 05 standard) and median of plasmas diluted 1:50. 
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Fig . 10. Antibody reactivity to HSP60 in plasmas of autistic 
subjects and normal controls. Shown are OD ratios (OD405 
samp le /OD405 standard) and median of plasmas diluted 1:100. 
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Fig . 11. Antibody reactivity to HSP60 in plasmas of autistic 
male subjects and normal male controls. Shown are OD ratios 
(OD405 sample/OD405 standard) and median of plasmas diluted 
1:50. Plasmas of autistic male subjects had significantly 
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Fig. 12 . Antibody reactivity to HSP60 in plasmas of autistic 
female subjects and normal female contro ls . Shown are OD 
ratios (OD405 sample/OD405 standard) and median of plasmas 
diluted 1:50. Plasma s of autistic female subjects did not 
have significantly (P=0 .933) elevated ratios. 
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The specificity of these results was also studied by 
first assay, the OD values competitive assays. In the 
obtained with plasmas incubated with the antigen (HSP60) 
solution were much lower (P<O.OOOl) than the OD values found 
with plasmas not incubated with the antigen solution (Fig. 
13) . In the second assay, OD values of the wells with 
competing antibody were significantly (P<O. 0335) lower than 
those of wells without competing antibody (Table 1) . 
The anti-HSP70 antibody levels were not correlated 
(r=0 .105; P=0.523) with anti-HSP60 antibody levels in plasmas 
of autistic subjects. Likewise, there was no correlation 
(r=0 .024; P=0.897) between these antibodies in plasmas of 
normal controls. 
The corre lation between ages of autistic subjects and 
antibody levels to HSP60 and HSP70 was also compared. The 
results showed no correlation (r=0.234; P=0.0.118) between 
ages of autistic subjects and the levels of anti-HSP60 
antibodies. Also, the ages of autistic subjects were not 
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Fig . 13. Antibody reactivity to HSP60. Absorbance values 
from the wells without competing antigens (white bars) and 
the wells with competing antigens (black bars) in plasmas of 
autistic subjects (#1, 2, & 3) and in plasmas of controls 
(#4, 5, 6 . & 7). The preparation of HSP60 antigen used to 
adsorb antibodies was the same as that of HSP60 antigen used 
to coat the plate. The absorbance values from the wells with 
competing antigens were significantly lower (P<O. 0001) than 
those of wells without competing antigens. 
Tab1e 1 . Specificity of pat ient and control plas masa in 
reactivity with HSP60 
Noncompetitiveb CompetitiveC % inhibiton 
Subjects OD OD 
1 0.431 0.137 68.21 
2 0.332 0.200 39.76 
3 0.258 0.128 50.39 
4 0 . 209 0.109 57.92 
a. Plasmas of autistic subjects (# 1 , 2 , & 3) and normal 
control (#4) diluted 1:50. 
b. Patient or control plasma alone. 
c. Patient or control plasma plus competing antibody. 
d. The OD values were significantly lower (P<0.0335) in the 
wells with competing antibody. 
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Investigation of crosseractivity 
between anti-HSP60 antibodies 
and anti-MBP monoclonal antibodies 
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In a first study of shared epitopes, patient plasmas 
yielding high OD values were allowed to compete with anti-MBP 
monoclonal antibodies for binding to HSP60 antigen coated in 
the plate. The control wells contained patient plasmas 
alone. The OD values of the wells with competing antibody 
were not significantly lower than those of wells without 
competing antibody (Table 2) In the second study , the 
sample wells were prepared the same way as those described in 
the first study except that anti-mous e Ig wa s added as an 
secondary antibody. The control wells contained anti -MBP 
monoclonal antibodies alone. Since the mouse anti-MBP 
monoclonal antibody did not bind to the coated antigen 
(HSP60) from E . coli, OD values for the wells with competing 
antibody and the wells without competing antibody were very 
low. No competition was found in the second study. 
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Table 2. Competition between patient plasmaa and monoclonal 
antibodies reactivity with MBP 
Noncompetitiveb CompetitiveC % Inhitition 
Subjects OD OD 
1 0.51 0 . 53 0 
2 0.34 0.31 8.8 
3 0.98 0.94 4.1 
a. OD values from plasmas diluted 1:50. 
b. Patient plasma alone. 
c. Patient plasma plus monoclonal antibodies that were 
reactive with myelin basic protein. 




Money et al. (1971) suggested that autism might be the 
result of the autoimmune mechanisms that damage the central 
nervous system. Several recent immunological studies have 
shown that autism shares certain features with established 
autoimmune diseases. For example, autism exhibits a greater 
concordance rate in monozygotic twins than in the same-sex 
dizygotic twins, a genetic predisposition factor that is also 
found in autoimmune diseases such as insulin-dependent 
diabetes and rheumatoid arthritis (Folstein and Rutter, 
1988) . Autistic disorder occurs more often in males. Thi s 
gender factor is also common in ankylosing spondylitis, which 
occurs more often in males , and systemic lupus erythematosus 
(SLE), which occurs more often in females. Singh et al. 
(1 991) found that the cytokines interleukin-2 and T8 are 
increased in the sera of autistic children; likewise, similar 
findings are also found in other autoimmune diseases such as 
mu l tiple sclerosis (Trotter et al. , 1988) and SLE (Huang et 
al., 1988) . Many of the a ut oimmune diseases are associated 
wi t h particular MHC haplotypes. For instance, ankylosing 
spondylitis is strongly associated with HLA- B27 antigen; 
juvenile rheumatoid arthritis is associated with HLA-DRS 
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antigen; and rheumatoid arthritis is associated with HLA-DR4 
antigen (Stastny et al., 1983). Warren et al. (1992) found 
an association of an extended MHC haplotype B44-SC30-DR4 with 
autism and have suggested that a gene somewhere within the 
extended haplotype may be responsible for some cases of 
autism. 
This study found a significant increase of anti-HSP70 
antibody levels in autistic subjects. Four possible 
pathogenic mechanisms can be generated from these results. 
First, since three members of the HSP70 gene family have been 
mapped to the MHC class III region in man (Sargent et al., 
1989; Milner et al., 1992) and members of HSP70 are known to 
be involved in immune response, one can imply that the HSP70 
gene may cont ribute to immune genetic susceptibility to 
autism. Warren et al. (1991) also reported that the 
frequency of the C4B null allele is increased in autism and 
in a subsequent study found that the C4B null allele results 
in decreased plasma levels of the C4B protein in some 
autistic subjects (Warren et al., 1994) The products of the 
C4B gene are crucial in protecting against invading 
microorganisms. The C4B gene is also important because of 
its location in the middle of the extended MHC complex and 
its closeness to the HSP70 genes . It is not unreasonable 
that an allele of HSP70 gene may be inherited with the C4B 
null gene and may contribute to the susceptibility or 
development of autism. 
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Second, Pociot et al. (1993) studied the functional 
implication of the polymorphism in the heat-shock inducible 
72kDa HSP gene in IDDM and showed that people who carry the 
Pst I 8.5-kb allele consistently had slightly lower 
expression than individuals who carry the 9. 0-kb allele. 
Therefore, it is feasible that a subgroup of autistic 
subjects carries an allele that results in higher production 
of HSP70 . In addition, autism has been associated with 
organisms causing gestational pathology, including prenatal 
rubella, cytomegalovirus, syphilis, and variolla (Desmond et 
al., 1970; Chess et al., 1971; Feldman et al., 1973; Knobloch 
and Pasmanick, 1974) . In a normal cell (e.g., brain cell or 
nerve cell), heat shock proteins exist inside the cell 
compartments, such as cytoplasm and mitochondria. However, 
these proteins may be expressed on the cell surface after an 
insult by some stressors such as heat, viral infection (e . g., 
cytomegalovirus and rubella virus), etc. The increased 
expression of cell surface HSP70 may be considered foreign by 
the immune system, giving rise to a primary autoimmune 
reaction against HSP70, and may lead to the neurobehavi or 
syndromes of autism. 
Third, due to the extreme conservation of the primary 
structure of HSP70 and the expression of this protein in a 
number of organisms, it is possible that in autism anti - HSP70 
antibody raised against a bacterial HSP70 epitope crossreacts 
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with brain cells or nerve cells containing similar epitope 
motifs with HSP 70. 
Fourth, HSP70 might have something to do with autism, 
and the high antibody levels toward HSP70 might relate to 
autism or be a marker for autism. It is possible that HSP70 
is required to keep repairing nerve or brain cells. Perhaps 
the high levels of anti-HSP70 antibodies modify or block the 
action of HSP70. Therefore, HSP70 may be unable to function 
properly. Such inactivation by anti-HSP70 antibodies could 
lead to some symptoms of autism. 
On the other hand, some normal subjects had high levels 
of HSP70 antibodies in their plasma. The occurrence of these 
antibodies might be due either to some previous self-limited 
infections with certain organisms having immunogens 
homologou s to HSP70 or to naturally occurring antibodies. 
It is possible that immune responses to heat-shock 
proteins are normal, but other factors (e.g., MHC haplotype, 
environment, etc.) alter the normal immune responses to heat-
shock protein. Several investigators have reported abnormal 
immune systems in autistic subjects. For example, the 
subjects have hyporesponses to the rubella antigen (Stubbs, 
1976). In that light, it is possible that since both 
au t istic subjects and normal controls do mount immune 
responses toward HSP70, the high antibody levels in plasmas 
of the auti s tic subjects might be the result of an abnormal 
immu ne system . It ma y also due to the defect in the 
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regulation of antibody response. Autistic subjects may make 
more antibodies toward HSP70 or their antibodies against 
HSP70 have a longer biological half life. 
The specificity of the reactive plasma was studied using 
a competitive ELISA. In this assay, soluble HSP70 was used 
to remove antibodies specifically against HSP70 in plasmas. 
Since the purificat ion technique for different preparations 
of HSP70 likely results in distinct impurities which might 
affect the results of this assay, two different preparations 
of HSP70 purchased from different companies were used in this 
study . The results suggested that the antibodies measured in 
this assay were directed against HSP70 and not the 
impuritie s . 
Four controls were used in the study of anti-HSP70 
antibodies . Among them, the wells containing standard 
plasma s alone were used to e liminate the false positive 
resul ts due to the reaction between bovine serum albumin 
(BSA) in blocking so lution and anti-BSA antibodies in human 
plasmas. Two autistic subjects were found to have antibodies 
against BSA; therefore, these samples were excluded from this 
assay. Nevertheless , it is possible that there are some 
antibodies against bovine proteins that can never be ruled 
out. 
The levels of HSP60 antibodies in the plasmas of 
au tistic subjects showed considerable individual variation 
and were not significantly increased above the mean antibody 
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levels of the normal control group. However, antibody levels 
in plasmas of 13 out of 41 autistic subjects were 
significantly elevated above the upper 95% confidence limits 
of the control subjects. In this subgroup of autistic 
subjects, further analysis of the specificity of antibodies 
will be required to verify reactivity against E. coli HSP60 
and not contaminated E. co li proteins. 
Since MBP shares sequence homology with human HSP60, and 
since HSP60 proteins are highly conserved within organisms, 
it is possible that antibo dies against foreign HSP60 of 
microorganisms crossre ac t with human HSP60 and MBP on brain 
cells, leading to neurobehavior syndromes of autism. 
However, in this study, using a competition assay, no 
crossreactivity was f o und between the anti-MBP monoclonal 
antibodie s and anti-HSP60 antibo die s from the autistic 
patients. Conceivably the anti-MBP monoclonal antibodies 
used in thi s study were specific for an epitope that is not 
shared with HSP60 and would not be informative in assessing 
crossreaction with anti-HSP60 antibodies. It would be 
valuable in future research to study this competition assay 
by using polyclonal anti-MBP antibodies. 
The finding in the study on anti-HSP antibodies in 
autistic patients, once again, suggests an association 
between autism and autoimmune disease. These results provide 
a stimulu s fo r further research on HSP genes in autistic 
pat i e nts . 
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